UC Davis Health Ventures will make an investment in Delix Therapeutics Inc., which has licensed UC Davis technology to develop non-hallucinogenic neuroplastogens as novel treatments for depression and ...
Davis scientists and researchers discuss new technology that helps people who cannot speak because of ALS. Next To Trump, Carney Opens G7 Summit With Warning Meet Alexandr Wang, the 28-Year-Old Who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results